✦ LIBER ✦

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

✍ Scribed by Regan, M. M.; Leyland-Jones, B.; Bouzyk, M.; Pagani, O.; Tang, W.; Kammler, R.; Dell'Orto, P.; Biasi, M. O.; Thurlimann, B.; Lyng, M. B.; Ditzel, H. J.; Neven, P.; Debled, M.; Maibach, R.; Price, K. N.; Gelber, R. D.; Coates, A. S.; Goldhirsch, A.; Rae, J. M.; Viale, G.

Book ID: 118051165
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 529 KB
Volume: 104
Category: Article
ISSN: 0027-8874
DOI: 10.1093/jnci/djs125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant letrozole versus tamoxifen acco

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

✍ Birgitte B Rasmussen; Meredith M Regan; Anne E Lykkesfeldt; Patrizia Dell'Orto; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 213 KB

Interpreting breast international group

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB

Switching of postmenopausal women with e

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

✍ Raimund Jakesz; Walter Jonat; Michael Gnant; Martina Mittlboeck; Richard Greil; 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 105 KB

Prevalent breast cancer patients with a

Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users

✍ A. S. Dieudonné; D. Lambrechts; B. Claes; T. Vandorpe; H. Wildiers; D. Timmerman 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 224 KB

Cognitive function in postmenopausal bre

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

✍ Kelly-Anne Phillips; Julie Aldridge; Karin Ribi; Zhuoxin Sun; Alastair Thompson; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 241 KB

Design, conduct, and analyses of Breast

Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

✍ Giobbie-Hurder, A.; Price, K. N; Gelber, R. D 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 194 KB